ROCKET PHARMACEUTICALS, INC. (RCKT)

PriceLoading quote

Financial charts

Revenue

Net income

Free cash flow

Total cash / debt

CashTotal debt

Financial statements

12 annual periodsNewest to oldest
202520242023202220212020201920182017201620152014
Revenue$0$0$0$0$0$0$0$0$0$0
Research & development$142.0M$171.2M$186.3M$165.6M$125.5M$105.4M$57.9M$53.3M$14.9M$6.0M$12.6M$5.6M
Operating expenses$231.7M$273.2M$259.7M$224.3M$167.2M$134.3M$76.2M$71.2M$19.8M$7.6M
Operating income−$231.7M−$273.2M−$259.7M−$224.3M−$167.2M−$134.3M−$76.2M−$71.2M−$19.8M−$7.6M−$20.4M−$7.7M
EBITDAderived−$222.8M−$266.0M−$254.8M−$220.4M−$164.0M−$133.2M−$75.7M−$70.8M
Net income−$223.1M−$258.7M−$245.6M−$221.9M−$169.1M−$139.7M−$77.3M−$74.5M−$19.6M−$7.6M−$68.0M−$9.5M
Basic EPSper diluted share-$2.01-$2.73-$2.92-$3.26-$2.67-$2.52-$1.58-$1.89-$2.88-$1.11-$3.72-$13.52
Diluted EPSper diluted share-$2.01-$2.73-$2.92-$3.26-$2.67-$2.52-$1.58-$1.89-$2.88-$1.11-$3.72-$13.52

Insider buys & sells

Jul 1, 2024Jun 30, 2026
Buys4$269.3K disclosed value
Sells (SEC code S)65$1.99M disclosed value
69 recent transactions
TransactionInsiderTypeSharesPriceValueOwned after
May 21, 2026Form 4Shah GauravCEOSellCommon Stock55.7K$3.09$172.1K1.06M
May 19, 2026Form 4Shah GauravCEOSellCommon Stock2.4K$3.01$7.3K1.04M
May 19, 2026Form 4Wilson MartinGeneral CounselSellCommon Stock662$3.01$2.0K678.0K
May 19, 2026Form 4Militello JohnSee RemarksSellCommon Stock384$3.01$1.2K89.8K
May 13, 2026Form 4Wilson MartinGeneral CounselSellCommon Stock3.4K$3.61$12.1K678.6K